The Review

The Journal of CAR T-Cell Therapy is an international science & medicine-focused news publication designed to serve the needs of a diverse community, including academia, life sciences, pharma, clinical research, clinicians, and physicians. Along with global clinical and regulatory news, we also cover payor and policy-related news and updates.

© Copyright 2025, 2026 Sunvalley Communication, LLC and AAMEI®, American Association for Medical Education and Information - All Rights Reserved.

Quick Links

Must Read

‘Eureka Moment’ in Tumor Treatment: Nearly One in Five People Diagnosed with Cancer wiling to Choose an Innovative Therapy

SITC 2025: Macrophage-targeting CAR monocytes Improve Immunotherapy Outcomes in Breast Cancer

Jiahui International Cancer Center Successfully Treats a 78-year-old Patient from New Zealand with Advanced CAR T-Cell Therapy

SITC 2025: Results from the Phase 1 / 2a AERIAL Trial Evaluating Lateral CAR-T LEU011 for the Treatment of Solid Tumors

STAR-101 Study results Highlighted at the 17th International Mesothelioma Interest Group (iMig) 2025

ASCO 2025: Satricabtagene Autoleucel Significantly Improves PFS and OS in advanced Gastric or Gastroesophageal Junction Carcinoma

Results of a First-in-Human Study Demonstrates Feasibility of In Vivo CAR T-Cell Therapy in Systemic Lupus Erythematosus

Global Statistics